India vs Nepal: Share of e coli bloodstream infections due to antimicrobial resistant
India
77.53
in 2022
Nepal
77.06
in 2022
India rank
4th
Nepal rank
5th
Share of e coli bloodstream infections due to antimicrobial resistant over time
- India
- Nepal
How they compare
India currently reports 77.53 against 77.06 in Nepal, a difference of 0.47.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was India ahead.
India ranks 4th and Nepal ranks 5th of 46 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.82 | 71.3 | 8.52 | India |
| 2020s | 80.64 | 76.81 | 3.84 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, India or Nepal?
- India, at 77.53 against 77.06 in Nepal as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between India and Nepal?
- 0.47, with India ahead.
- How many years of comparable data are there for India and Nepal?
- 5 years are reported by both, from 2018 to 2022.
- How do India and Nepal rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- India ranks 4th and Nepal ranks 5th of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.